Some findings he included were really fascinating, such as that being out of normal sinus rhythm can cause inflammation, rather than the other way around. Also, inflammation may not be as important in true lone atrial fibrillation.
Importantly, most studies on afib and inflammation have been on populations that were mostly men. That’s why the statin study is so unique - it’s an afib study in WOMEN, FINALLY! We know that afib is slightly different in women and it’s nice to finally have some afib studies that tell us what happens for women.
So, if statins’ anti-inflammatory properties were beneficial for women (in this case, post-menopausal women with existing heart disease) by decreasing their atrial fibrillation risk, then natural anti-inflammatories should also be beneficial for many, if not most, women in decreasing their afib risk. We know that anti-inflammatories are beneficial to men, but it’s good to finally know that this applies to women as well.
Speaking of afib research on women, one study just presented at the Heart Rhythm Society annual meeting showed that women are way under-represented among those referred for catheter ablation. I know that to be the case for surgery as well.
So that means that if you’re a woman with afib, you just may have to be more proactive and assertive to find out all your options to get the atrial fibrillation treatment you deserve.